RGC
Regencell Bioscience Holdings Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$5.79
−2.85%Leverage
- Debt / equity
- 0.32x
- Net debt / equity
- -1.62x
- Debt / assets
- 0.13x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 0.28x
Liquidity & coverage
- Current ratio
- 1.42x
- Quick ratio
- 1.42x
- Cash ratio
- 1.42x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $691.4K
Cash & dividend
- FCF / debt
- -6.71x
- Cash flow / debt
- -6.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -75.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025